Researchers at this year's Heart Rhythm Society conference are still struggling to figure out the best way to manage patients still implanted with St. Jude Medical's recalled Riata defibrillator leads, but the company won some hearts with strong findings for its next-generation Optim-coated devices.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oJ6cHQ
Cap comentari:
Publica un comentari a l'entrada